To further investigate the sustained effect of the loss of PTPRS activity on ERK activation in CRC cell lines and compare to ISP inhibition and siRNA knockdown of PTPRS, we applied CRISPR technology to permanently knock out expression of PTPRS in the HCT116, SW620 and KM12L4A cell lines. Here, PTPRS is linked to colorectal carcinoma.